Vyvanse: effectiveness, side effects, alternatives in the real world

Number of reports submitted per year:

How effective is Vyvanse?

• Attention deficit hyperactivity disorder - reported by 4,701 people
• Binge eating - reported by 120 people
• Depression - reported by 44 people

Alternative drugs to the conditions Vyvanse treats:

• Attention deficit hyperactivity disorder
• Binge eating
• Depression

Vyvanse side effects by duration, gender and age:

• Vyvanse side effects (28,085 reports)

Browse all side effects of Vyvanse:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vyvanse and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Compare Vyvanse with similar drugs, by side effects and effectiveness:

• Vyvanse vs. Adderall
• Vyvanse vs. Adderall 10
• Vyvanse vs. Adderall 15
• Vyvanse vs. Adderall 20
• Vyvanse vs. Adderall 30
• Vyvanse vs. Adderall 5
• Vyvanse vs. Adderall xr 10
• Vyvanse vs. Adderall xr 15
• Vyvanse vs. Adderall xr 20
• Vyvanse vs. Adderall xr 25
• Vyvanse vs. Adderall xr 30
• Vyvanse vs. Adderall xr 5
• Vyvanse vs. Amphetamine salt combo
• Vyvanse vs. Atomoxetine
• Vyvanse vs. Clonidine
• Vyvanse vs. Concerta
• Vyvanse vs. Daytrana
• Vyvanse vs. Dexedrine
• Vyvanse vs. Dextroamphetamine sulfate
• Vyvanse vs. Focalin
• Vyvanse vs. Focalin xr
• Vyvanse vs. Guanfacine hydrochloride
• Vyvanse vs. Intuniv
• Vyvanse vs. Methylphenidate hydrochloride
• Vyvanse vs. Ritalin
• Vyvanse vs. Ritalin la
• Vyvanse vs. Strattera
• Vyvanse vs. Wellbutrin

Do you take Vyvanse?

- You can use our AI tools to monitor drug safety and effectiveness.

---

Related publications that referenced our studies

• Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
• Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
• Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
• Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
• Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
• Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all drugs on eHealthMe.